Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
HIV Infections
Interventions
DRUG

Nevirapine

Switch one of ARV drugs to Nevirapine

Trial Locations (17)

28040

Hospital Clínico San Carlos de Madrid, Madrid

38010

Hospital La Candelaria, Santa Cruz de Tenerife

43201

Hospital Universitari Sant Joan de Reus, Reus

43500

Hospital de Tortosa, Tortosa

46009

Hospital La Fe de Valencia, Valencia

50009

Hospital Miguel Servet, Zaragoza

08916

Hospital.Universitari Germans Trias i Pujol, Badalona

08009

Centre Penitenciari Brians, Barcelona

08025

Hopsital de Sant Pau, Barcelona

08035

Hospital Vall d'Hebron, Barcelona

08036

Hospital Clínic i Provincial de Barcelona, Barcelona

08370

Hospital Sant Jaume de Calella, Barcelona

Unknown

Centre Penitenciari Homes, Barcelona

08400

Hospital General de Granollers, Granollers

08430

Centre Penitenciari Quatre Camins, Granollers

08907

Hospital de Bellvitge, L'Hospitalet de Llobregat

08221

Mutua de Terrassa, Terrassa

All Listed Sponsors
lead

Hospital de Calella

OTHER

NCT00415090 - Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only | Biotech Hunter | Biotech Hunter